Skip to content
Recall Observatory FDA recall evidence

Drug product

Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 0527-4664-37

D-0599-2025

August 11, 2025

Class II

Product summary

Firm
Lannett Company Inc.
Event
Event 97397
Status
Terminated
Classification
Class II
Quantity
8544 bottles
Official record key
drug-enforcement:D-0599-2025

Official wording

Reason: Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules 30mg.

Code information: Lot #: 25280726A, Exp. Date 03/2027

Distribution pattern: Nationwide within the USA

Derived failure modes

  • Labeling or packaging

    reason.labeling_packaging · v1.0.0

    Labeling: Label Mix-up